In addition to weight reduction, treatment with mazdutide was associated with significant improvements in metabolic parameters, including reductions in glycated hemoglobin (HbA1c), fasting plasma glucose, blood pressure, and lipid profiles in individuals with type 2 diabetes mellitus
et al., Front Pharmacol, 2022
A 2021 study examined digestive side effects in people with overweight or obesity who received semaglutide in clinical trials
Desiccation is equally critical during cold storage
According to research in Diabetes, Obesity and Metabolism, patient-reported satisfaction with weight loss increases significantly after the first three months of treatment, when cumulative loss reaches meaningful levels
The study was funded by the manufacturer, so potential biases must be considered